FDA looking into marketing of unapproved cancer drug DCA

22

Mar

2007

According to an article by the CanWest News Service, the fraud division of the U.S. Food and Drug Administration (FDA) is looking into allegations that a website is selling the unapproved compound dichloroacetate, or DCA, to cancer patients. Neither the FDA nor Health Canada has approved DCA for use in humans.

Dr. Evangelos Michelakis of the University of Alberta, who discovered that DCA can shrink cancerous tumors of the lung, breast and other forms of cancer in rats, has warned that people could die if they took DCA. For the full article, go to www.canada.com.

email this page print this page permanent link

Related News

Baron & Budd, P.C.:
Since 1977, the law firm of Baron & Budd, P.C. has championed the rights of people and communities harmed by corporate misconduct. With over 50 attorneys and offices in Texas, California, and Louisiana, Baron & Budd enjoys a national reputation as a leader of the plaintiffs’ bar. The firm represents individuals with mesothelioma and other diseases caused by asbestos and injuries caused by other toxic substances and pharmaceuticals. The firm also represents water authorities seeking clean-up costs for drinking water contamination; securities investors and governmental entities defrauded by corporate wrongdoing; and consumers. For more information about Baron & Budd, call 800-222-2766 or contact us via our secure form.

 
Other Offices:
  • Baton Rouge, LA
  • Canton, NY
  • Beverly Hills, CA
  • Austin, TX
Main Office:
3102 Oak Lawn Avenue, Suite 1100
Dallas, TX 75219
For nearly 30 years, the law firm of Baron & Budd, P.C. has fought to safeguard the rights of mesothelioma victims and their families. MesotheliomaNews.com is a public service of Baron & Budd, P.C.

© 2008, Baron & Budd, P.C.